About the Gastrointestinal Carcinoid Tumor Session
Gastrointestinal carcinoid tumors, a rare subset among digestive tract malignancies, pose unique challenges in cancer research. Emerging studies spotlight their intricate molecular landscape and varied clinical behaviors, propelling efforts to unlock targeted therapies. Innovations in imaging technology play a pivotal role, facilitating early diagnosis and accurate staging for tailored treatment plans. Collaborative interdisciplinary endeavors underscore the quest for personalized approaches, uniting oncologists, pathologists, and researchers in the pursuit of enhanced patient outcomes. As incidence rates climb, understanding the nuanced nature of these tumors becomes paramount, driving forward the frontier of gastrointestinal oncology.
Topics Covered in Gastrointestinal Carcinoid Tumor
Small Bowel Primaries
Carcinoid Syndrome
Proliferation Grading
Somatostatin Receptor PET
Somatostatin Analogs
Radioligand Therapy
Related Scientific Sessions at CIOC 2027
Why Attend the Gastrointestinal Carcinoid Tumor Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Gastrointestinal Carcinoid Tumor work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Gastrointestinal Carcinoid Tumor research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Gastrointestinal Carcinoid Tumor track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Gastrointestinal Carcinoid Tumor Conference 2027 — FAQs
What is the Gastrointestinal Carcinoid Tumor track at CIOC 2027?
The Gastrointestinal Carcinoid Tumor track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Gastrointestinal Carcinoid Tumor. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Gastrointestinal Carcinoid Tumor sessions?
Cancer researchers and clinicians, educators and students with an interest in Gastrointestinal Carcinoid Tumor are all welcome — whether presenting or attending.
Can I present my research in the Gastrointestinal Carcinoid Tumor track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Gastrointestinal Carcinoid Tumor sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Gastrointestinal Carcinoid Tumor track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.